Apollo Hospitals and Fortis Healthcare are also witnessing higher...
Category:
Pandemic
Latest
New Zealand to move into New Covid Protection System on Dec 3
The simplified framework has three levels: green, orange, and red....
Slump in births in Kerala during COVID pandemic
Kerala had witnessed 37,138 births in July 2020. But the state in...
Denmark, Norway, Iceland suspend use of AstraZeneca vaccine
“This is a super-cautious approach based on some isolated reports in Europe,” said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine.
Maharashtra:Two health officials test Covid postive after 2nd vaccine dose
Additional civil surgeon Padmaja Saraf said it takes around 42 days for the antibodies to develop after both the doses of the vaccine are administered.
“One must wear a mask and adhere to all COVID-19 protocols even after taking both the doses of the vaccine,” she said.
India reports 22,854 new coronavirus cases, 126 deaths in last 24 hrs
Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu continue to report a high number of fresh COVID-19 cases and together account for 85.91 per cent of the new cases of the coronavirus infection reported in the country in a span of 24 hours, the Union health ministry said on Thursday.Meanwhile, the nationwide COVID-19 vaccination has reported 2,52,89,693 crore coverage, as per the information shared by the union health ministry yesterday.
India reports 17,921 new coronavirus cases, 133 deaths in last 24 hrs
With 96,548 active coronavirus infections, Maharashtra has the highest number of active cases. Kerala follows with 37,446 active COVID-19 cases. As many as 2,43,67,906 vaccine doses have been administered so far.
Intranasal Covid vaccine candidate in early clinical stage of development in India: Govt
“The interval period between the two doses is presently 21 days. The schedule will be finalized after the phase I clinical trial data. Currently, in phase I clinical trial, single dose and two dose schedules are being tested,” the minister said.
Pfizer wants to make vaccine in India if faster clearance, export freedom assured -sources
Pfizer and Moderna, whose shots are more expensive than the AstraZeneca one being used in India’s immunisation campaign, are not comfortable with strict price and export restrictions, one of the sources said.
Bharat’s COVID shot shows high immune response, further study needed for elderly
Less than 9% of the more than 18.2 million Indians vaccinated so far against COVID-19 had taken COVAXIN as of Tuesday, government data showed.
COVID-19 vaccine rollout by India has ‘rescued the world’ from pandemic: top US scientist
India has provided 56 lakh doses of coronavirus vaccines under grants assistance to a number of countries. The vaccines were sent to Sri Lanka, Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles.
There has also been a boost in the collaborative medical partnerships emerging between the US and India during this pandemic. In addition, India is one of the fourth largest destinations in Asia for medical devices manufacturing and many US companies have expressed interest in collaborating on this front,” Mahajan said.
COVID-19: India records 18,599 new cases, 97 fresh fatalities
Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu are the six states that cumulatively account for 86.25 per cent of the new coronavirus cases reported in the past 24 hours, the Health Ministry said on Monday.
Maharashtra has reported the highest daily new cases at 11,141, followed by Kerala with 2,100 and Punjab with 1,043 new infections, the ministry said.
Austria suspends AstraZeneca COVID-19 vaccine batch after death
One 49-year-old woman died as a result of severe coagulation disorders, while a 35-year-old woman developed a pulmonary embolism and is recovering, it said. A pulmonary embolism is an acute lung disease caused by a dislodged blood clot. “Currently there is no evidence of a causal relationship with the vaccination,” BASG said.